BOARD OF VISITORS EXECUTIVE SUMMARY
HEALTH AFFAIRS COMMITTEE
Friday, October 15, 1999
11:45 a.m. 12:30 p.m.
East Oval Room, The Rotunda
I. CONSENT AGENDA
- Conflict of Interest Exemption (Adenosine Therapeutics, LLC) -- Approves the exemption from the Virginia Conflict of Interest Act be granted for research contracts for developing therapeutic agents between the University of Virginia and "ADENOSINE THERAPEUTICS, LLC", a Virginia corporation.
II. REPORTS BY THE VICE PRESIDENT AND PROVOST FOR HEALTH SCIENCES
A. Medical Center Financial Report (as of June 30, 1999) -- Mr. Fitzgerald, the Health System's new Chief Financial Officer, will report on the Medical Cneter's financial results for Fiscal Year 1998-1999 and comment on trends observed yearto-date this Fiscal Year.
B. Medical Center Process Review -- Mr. Carter will review steps underway to streamline the Medical Center's administrative and clinical activities to effect savings.
C. Vice Presidents Remarks -- Dr. Cantrell will report on significant developments and events impacting the Health System that have occurred since the last meeting.
Maintained by email@example.com
Last Modified: Thursday, 02-Jul-2009 08:16:59 EDT
© 2000 by the Rector and Visitors of the University of Virginia
Information: 434 924-0311